Pfizer manuevers to shield Lipitor from generics
TRENTON, N.J. (AP) - November 29, 2011 (WPVI) -- Pfizer is getting creative to preserve Lipitor's billions in sales as the cholesterol drug gets generic competition in the U.S. market.
Pfizer is offering unprecedented discounts and incentives for patients, insurers and companies that process prescriptions. The deals will make the brand name as cheap as or cheaper than generics that go on sale Wednesday.
Normally when a drug's patent ends, generics grab nearly all its market share within a year. Pfizer isn't giving up that easy on Lipitor. The drug still brings in nearly $11 billion a year, a sixth of Pfizer's revenue.
Sanford Bernstein analyst Tim Anderson estimates Pfizer can still make a $100 profit on a 90-day supply of Lipitor under the deals. That's about half what it makes now.
- Photos: AccuWeather Maps: Snow arrives
- Snow will turn the ground white again!
- Get the 6abc StormTracker app
- WATCH: Action News Online
- Woman, 98, injured in Powelton high-rise fire
- Mike Schmidt reveals skin cancer battle
- Police: Driver, who hit pedestrian, hit by car
- Malaysian police examine pilot's flight simulator
- Crimeans vote to leave Ukraine, join Russia
- March Madness: Villanova, St. Joe's, UDel all in
- Delaware man suspected in 14 different thefts
- NJ salon customer allegedly attacks employees
- NJ state police trooper among 3 injured in crash
- Book 'em! Wilmington cop donates books to kids